UCB Japan Co. Ltd. clinical trials

A country office of UCB S.A.

The registry lists 14 studies whose lead sponsor is UCB Japan Co. Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 3, 2025.

Studies

Recruiting first, then most recently updated. Showing 14 of 14. All UCB S.A. studies →

• A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)CompletedNCT01228747Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of AgeCompletedNCT03340064Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset SeizuresCompletedNCT00367432Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset SeizuresCompletedNCT02124564Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label MethodCompletedNCT00160615Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset SeizuresCompletedNCT02192814Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal EpilepsyCompletedNCT01506882Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic SeizuresCompletedNCT01292837Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• Maintenance Study of Certolizumab Pegol (CZP) in Crohn's DiseaseCompletedNCT00329550Phase 2

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial SeizuresCompletedNCT01063764Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset SeizuresCompletedNCT00280696Phase 3

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy MalesCompletedNCT01725009Phase 1

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) TherapyCompletedNCT01463059Phase 2

  Sponsor listed in the registry: UCB Japan Co. Ltd.

• An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset SeizuresCompletedNCT01407523Phase 2

  Sponsor listed in the registry: UCB Japan Co. Ltd.